Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (181-190 of 268) with videos related to

Pageof 27
Sort By:
Brain : a Journal of Neurology|November 24, 2025
Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosisMaxime Bigotte, Adam M R Groh, Elia Afanasiev, et al.
Nature Medicine|May 10, 2016
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptorVeit Rothhammer, Ivan D Mascanfroni, Lukas Bunse, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive EvaluationSamuel Mailhot-Larouche, Vincent Chauvette, David Bergeron, et al.
The Journal of Clinical Investigation|April 10, 2018
Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesisHania Kebir, Lionel Carmant, François Fontaine, et al.
Nature|February 14, 2020
MAFG-driven astrocytes promote CNS inflammationMichael A Wheeler, Iain C Clark, Emily C Tjon, et al.
Nature Neuroscience|March 3, 2025
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse modelAtsushi Kadowaki, Michael A Wheeler, Zhaorong Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2023
Risk of secondary progressive multiple sclerosis after early worsening of disabilityWinston Dzau, Sifat Sharmin, Francesco Patti, et al.
Brain : a Journal of Neurology|August 28, 2023
ALCAM on human oligodendrocytes mediates CD4 T cell adhesionHélène Jamann, Haritha L Desu, Qiao-Ling Cui, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Tim Spelman, et al.
Nature|January 4, 2023
Identification of astrocyte regulators by nucleic acid cytometryIain C Clark, Michael A Wheeler, Hong-Gyun Lee, et al.
Pageof 27

Showing results (181-190 of 268) with videos related to

Sort By:
Pageof 27
Brain : a Journal of Neurology|November 24, 2025
Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosisMaxime Bigotte, Adam M R Groh, Elia Afanasiev, et al.
Nature Medicine|May 10, 2016
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptorVeit Rothhammer, Ivan D Mascanfroni, Lukas Bunse, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive EvaluationSamuel Mailhot-Larouche, Vincent Chauvette, David Bergeron, et al.
The Journal of Clinical Investigation|April 10, 2018
Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesisHania Kebir, Lionel Carmant, François Fontaine, et al.
Nature|February 14, 2020
MAFG-driven astrocytes promote CNS inflammationMichael A Wheeler, Iain C Clark, Emily C Tjon, et al.
Nature Neuroscience|March 3, 2025
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse modelAtsushi Kadowaki, Michael A Wheeler, Zhaorong Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2023
Risk of secondary progressive multiple sclerosis after early worsening of disabilityWinston Dzau, Sifat Sharmin, Francesco Patti, et al.
Brain : a Journal of Neurology|August 28, 2023
ALCAM on human oligodendrocytes mediates CD4 T cell adhesionHélène Jamann, Haritha L Desu, Qiao-Ling Cui, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Tim Spelman, et al.
Nature|January 4, 2023
Identification of astrocyte regulators by nucleic acid cytometryIain C Clark, Michael A Wheeler, Hong-Gyun Lee, et al.
Pageof 27